Clinical Trial Update: Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study comparing two fixed-dose combinations of amlodipine and losartan (FDC5/50 and FDC5/100) under fasting conditions to determine bioequivalence; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Losartan (losartan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED